Frederick A. Schroeder

2.3k total citations
30 papers, 1.5k citations indexed

About

Frederick A. Schroeder is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Frederick A. Schroeder has authored 30 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Pharmacology. Recurrent topics in Frederick A. Schroeder's work include Histone Deacetylase Inhibitors Research (15 papers), Epigenetics and DNA Methylation (6 papers) and Protein Degradation and Inhibitors (6 papers). Frederick A. Schroeder is often cited by papers focused on Histone Deacetylase Inhibitors Research (15 papers), Epigenetics and DNA Methylation (6 papers) and Protein Degradation and Inhibitors (6 papers). Frederick A. Schroeder collaborates with scholars based in United States, Belgium and Germany. Frederick A. Schroeder's co-authors include Schahram Akbarian, Wim E. Crusio, Cong Lin, Jacob M. Hooker, Changning Wang, Stephen J. Haggarty, Christine Konradi, Florence F. Wagner, Hsiao‐Ying Wey and Ramesh Neelamegam and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Frederick A. Schroeder

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frederick A. Schroeder United States	20	963	306	282	247	182	30	1.5k
Rakesh Karmacharya United States	21	636 0.7×	150 0.5×	277 1.0×	262 1.1×	121 0.7×	46	1.6k
Zoya Marinova Switzerland	19	1.1k 1.1×	263 0.9×	612 2.2×	118 0.5×	238 1.3×	32	1.8k
Alessandra Caruso Italy	18	777 0.8×	230 0.8×	551 2.0×	154 0.6×	449 2.5×	36	1.6k
Yoko Kinoshita Japan	28	715 0.7×	571 1.9×	616 2.2×	308 1.2×	171 0.9×	73	2.1k
Heh‐In Im South Korea	18	1.1k 1.1×	256 0.8×	511 1.8×	131 0.5×	221 1.2×	40	1.9k
David P. Gavin United States	21	1.1k 1.1×	581 1.9×	188 0.7×	241 1.0×	89 0.5×	38	1.6k
Mary E. Hamby United States	16	541 0.6×	168 0.5×	466 1.7×	281 1.1×	306 1.7×	25	1.9k
Michelle Potter United States	15	667 0.7×	176 0.6×	450 1.6×	447 1.8×	311 1.7×	22	2.0k
Minae Niwa Japan	27	862 0.9×	213 0.7×	893 3.2×	315 1.3×	208 1.1×	56	2.0k
Myoung‐Sun Roh South Korea	17	667 0.7×	254 0.8×	442 1.6×	136 0.6×	108 0.6×	25	1.7k

Countries citing papers authored by Frederick A. Schroeder

Since Specialization

Citations

This map shows the geographic impact of Frederick A. Schroeder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick A. Schroeder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick A. Schroeder more than expected).

Fields of papers citing papers by Frederick A. Schroeder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick A. Schroeder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick A. Schroeder. The network helps show where Frederick A. Schroeder may publish in the future.

Co-authorship network of co-authors of Frederick A. Schroeder

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick A. Schroeder. A scholar is included among the top collaborators of Frederick A. Schroeder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick A. Schroeder. Frederick A. Schroeder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bekier, Michael E., Frederick A. Schroeder, Florence F. Wagner, et al.. (2025). A next-generation HDAC6 inhibitor for amyotrophic lateral sclerosis and frontotemporal dementia. Brain.

Koole, Michel, Donatienne Van Weehaeghe, Kim Serdons, et al.. (2020). Clinical validation of the novel HDAC6 radiotracer [18F]EKZ-001 in the human brain. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 596–611. 23 indexed citations

Campbell, Arthur J., Wen‐Ning Zhao, Frederick A. Schroeder, et al.. (2017). HDAC6 Brain Mapping with [¹⁸F]Bavarostat Enabled by a Ru-Mediated Deoxyfluorination. ACS Central Science. 3(9). 1006–1014. 61 indexed citations

Hooker, Jacob M., et al.. (2017). Imaging cardiac SCN5A using the novel F-18 radiotracer radiocaine. Scientific Reports. 7(1). 42136–42136. 5 indexed citations

Bittner, Genevieve C. Van de, Misha M. Riley, Luxiang Cao, et al.. (2017). Nasal neuron PET imaging quantifies neuron generation and degeneration. Journal of Clinical Investigation. 127(2). 681–694. 9 indexed citations

Schroeder, Frederick A., Tonya M. Gilbert, Ningping Feng, et al.. (2016). Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia. ACS Chemical Neuroscience. 8(3). 662–668. 35 indexed citations

Wang, Changning, Michael S. Placzek, Genevieve C. Van de Bittner, Frederick A. Schroeder, & Jacob M. Hooker. (2015). A Novel Radiotracer for Imaging Monoacylglycerol Lipase in the Brain Using Positron Emission Tomography. ACS Chemical Neuroscience. 7(4). 484–489. 26 indexed citations

Wang, Changning, Frederick A. Schroeder, Michael S. Placzek, et al.. (2015). Development of a Fluorinated Class-I HDAC Radiotracer Reveals Key Chemical Determinants of Brain Penetrance. ACS Chemical Neuroscience. 7(5). 528–533. 23 indexed citations

Neelamegam, Ramesh, et al.. (2014). Imaging Evaluation of 5HT_2C Agonists, [¹¹C]WAY-163909 and [¹¹C]Vabicaserin, Formed by Pictet–Spengler Cyclization. Journal of Medicinal Chemistry. 57(4). 1488–1494. 50 indexed citations

10.

Wang, Changning, Frederick A. Schroeder, Hsiao‐Ying Wey, et al.. (2014). In Vivo Imaging of Histone Deacetylases (HDACs) in the Central Nervous System and Major Peripheral Organs. Journal of Medicinal Chemistry. 57(19). 7999–8009. 75 indexed citations

11.

Wang, C., Frederick A. Schroeder, & Jacob M. Hooker. (2013). Visualizing epigenetics: Current advances and advantages in HDAC PET imaging techniques. Neuroscience. 264. 186–197. 34 indexed citations

12.

Schroeder, Frederick A., Michael C. Lewis, Daniel M. Fass, et al.. (2013). A Selective HDAC 1/2 Inhibitor Modulates Chromatin and Gene Expression in Brain and Alters Mouse Behavior in Two Mood-Related Tests. PLoS ONE. 8(8). e71323–e71323. 105 indexed citations

13.

Wang, Changning, Colin M. Wilson, Stephen M. Carlin, et al.. (2013). Evaluation of potential PET imaging probes for the orexin 2 receptors. Nuclear Medicine and Biology. 40(8). 1000–1005. 19 indexed citations

14.

Schroeder, Frederick A., Daniel B. Chonde, Misha M. Riley, et al.. (2013). FDG-PET imaging reveals local brain glucose utilization is altered by class I histone deacetylase inhibitors. Neuroscience Letters. 550. 119–124. 12 indexed citations

15.

Fass, Daniel M., Frederick A. Schroeder, Roy H. Perlis, & Stephen J. Haggarty. (2013). Epigenetic mechanisms in mood disorders: Targeting neuroplasticity. Neuroscience. 264. 112–130. 47 indexed citations

16.

Jiang, Yan, Mira Jakovcevski, Rahul Bharadwaj, et al.. (2010). Setdb1 Histone Methyltransferase Regulates Mood-Related Behaviors and Expression of the NMDA Receptor Subunit NR2B. Journal of Neuroscience. 30(21). 7152–7167. 93 indexed citations

17.

Febo, Marcelo, Schahram Akbarian, Frederick A. Schroeder, & Craig F. Ferris. (2009). Cocaine-induced metabolic activation in cortico-limbic circuitry is increased after exposure to the histone deacetylase inhibitor, sodium butyrate. Neuroscience Letters. 465(3). 267–271. 16 indexed citations

18.

Schroeder, Frederick A., Anouch Matevossian, Sara R. Jones, et al.. (2008). Drug-Induced Activation of Dopamine D1 Receptor Signaling and Inhibition of Class I/II Histone Deacetylase Induce Chromatin Remodeling in Reward Circuitry and Modulate Cocaine-Related Behaviors. Neuropsychopharmacology. 33(12). 2981–2992. 104 indexed citations

19.

Schroeder, Frederick A., Cong Lin, Wim E. Crusio, & Schahram Akbarian. (2006). Antidepressant-Like Effects of the Histone Deacetylase Inhibitor, Sodium Butyrate, in the Mouse. Biological Psychiatry. 62(1). 55–64. 418 indexed citations

20.

Li, Jianhong, Yin Guo, Frederick A. Schroeder, et al.. (2004). Dopamine D₂‐like antagonists induce chromatin remodeling in striatal neurons through cyclic AMP‐protein kinase A and NMDA receptor signaling. Journal of Neurochemistry. 90(5). 1117–1131. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact